KalVista Pharmaceuticals (KALV) Stock Chart & Stock Price History $12.41 -0.25 (-1.97%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$12.68 +0.27 (+2.14%) As of 08/8/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KalVista Pharmaceuticals Stock Price Performance The KalVista Pharmaceuticals (KALV) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 3.80%, with a year-to-date return of 46.52%. In the past month, the stock has decreased 22.39%, reflecting recent market activity. As of the latest close, KalVista Pharmaceuticals traded at $12.41 with a market cap of $619.88 million and volume of 585,128 shares. Five years ago, the stock traded at $11.60, representing a 6.98% increase over that period. At the time, it had a market cap of $204.56 million and a volume of 34,225 shares. Receive KALV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-6.76%1 Month Performance-22.39%3 Month Performance+4.29%Year-To-Date Performance+46.52%1 Year Performance-3.80%5 Year Performance+6.98% KALV Stock Chart for Saturday, August, 9, 2025 KALV Chart by TradingView KalVista Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/08/2025$12.66$12.41-1.97%$12.81$12.19585,128 shs$619.88 million08/07/2025$12.77$12.66-0.86%$12.87$12.41645,870 shs$632.37 million08/06/2025$13.05$12.77-2.15%$13.04$12.51656,550 shs$637.86 million08/05/2025$13.31$13.05-1.95%$13.35$12.85701,547 shs$651.85 million08/04/2025$13.21$13.31+0.76%$13.54$13.10985,422 shs$664.83 million08/01/2025$13.63$13.21-3.08%$13.83$13.19856,421 shs$659.84 million07/31/2025$13.84$13.63-1.52%$13.86$13.43766,046 shs$680.87 million07/30/2025$13.75$13.84+0.65%$14.35$13.69923,607 shs$691.31 million07/29/2025$13.57$13.75+1.33%$13.93$13.26981,568 shs$686.81 million07/28/2025$14.58$13.57-6.93%$14.78$13.551.89 million shs$677.88 million Get the Latest News and Ratings for KALV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/25/2025$15.60$14.58-6.54%$15.63$14.481.01 million shs$728.33 million07/24/2025$15.56$15.60+0.26%$15.76$15.36745,675 shs$779.22 million07/23/2025$15.81$15.56-1.58%$16.09$15.531.16 million shs$777.22 million07/22/2025$15.56$15.81+1.61%$15.91$15.21738,013 shs$789.77 million07/21/2025$15.39$15.56+1.10%$15.74$15.20710,610 shs$777.22 million07/18/2025$16.01$15.39-3.87%$16.23$15.301.28 million shs$768.73 million07/17/2025$15.79$16.01+1.39%$16.20$15.591.89 million shs$799.70 million07/16/2025$15.17$15.79+4.09%$15.85$15.091.20 million shs$788.77 million07/15/2025$15.22$15.17-0.33%$15.24$14.671.42 million shs$757.74 million07/14/2025$14.52$15.22+4.82%$15.24$13.851.38 million shs$760.24 million07/11/2025$15.51$14.52-6.38%$15.00$13.852.09 million shs$721.93 million07/10/2025$15.99$15.51-3.00%$16.32$15.081.98 million shs$771.16 million07/09/2025$14.95$15.99+6.96%$16.11$14.953.01 million shs$794.96 million07/08/2025$15.06$14.95-0.73%$16.14$14.813.43 million shs$743.31 million Related Companies CRNX Stock Price Chart IMVT Stock Price Chart ALVO Stock Price Chart MOR Stock Price Chart OGN Stock Price Chart NAMS Stock Price Chart RXRX Stock Price Chart GMTX Stock Price Chart RARE Stock Price Chart MIRM Stock Price Chart Receive KALV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KALV) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KalVista Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KalVista Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
